Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

Primary testicular lymphoma

Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukaemia

WATCH: Interview with Prof Cheah regarding ECHO Trial

WATCH: Interview with our Lymphoma Nurse Practitioner

Interim Safety Analysis of ALLG-Pacific (NHL35)

Preliminary Results of a Phase 1, Dose-Escalation Study of PRT2527

“The End of the Golden Weather”: therapeutic strategies for mantle cell lymphoma relapsed or refractory to covalent BTK inhibitors

Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial

WATCH: An Interview with Dr Jamie Brennan